COLTENE Holding Past Earnings Performance
Past criteria checks 2/6
COLTENE Holding has been growing earnings at an average annual rate of 7.1%, while the Medical Equipment industry saw earnings growing at 7.6% annually. Revenues have been growing at an average rate of 2% per year. COLTENE Holding's return on equity is 12.3%, and it has net margins of 4.9%.
Key information
7.1%
Earnings growth rate
4.8%
EPS growth rate
Medical Equipment Industry Growth | 11.1% |
Revenue growth rate | 2.0% |
Return on equity | 12.3% |
Net Margin | 4.9% |
Next Earnings Update | 08 Aug 2024 |
Recent past performance updates
Recent updates
Earnings Update: COLTENE Holding AG (VTX:CLTN) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts
Mar 13COLTENE Holding AG's (VTX:CLTN) Business And Shares Still Trailing The Market
Jan 21At CHF83.10, Is COLTENE Holding AG (VTX:CLTN) Worth Looking At Closely?
Jun 15COLTENE Holding AG (VTX:CLTN) Analysts Are Pretty Bullish On The Stock After Recent Results
Mar 08Should You Investigate COLTENE Holding AG (VTX:CLTN) At CHF88.90?
Mar 08Is COLTENE Holding (VTX:CLTN) Using Too Much Debt?
Nov 09Is It Time To Consider Buying COLTENE Holding AG (VTX:CLTN)?
Sep 29COLTENE Holding (VTX:CLTN) Has A Pretty Healthy Balance Sheet
May 29How Does COLTENE Holding AG (VTX:CLTN) Fare As A Dividend Stock?
Apr 01Is Now The Time To Look At Buying COLTENE Holding AG (VTX:CLTN)?
Mar 14Shareholders Of COLTENE Holding (VTX:CLTN) Must Be Happy With Their 84% Return
Feb 24Is COLTENE Holding AG's (VTX:CLTN) ROE Of 16% Impressive?
Jan 28Is COLTENE Holding AG's (VTX:CLTN) Shareholder Ownership Skewed Towards Insiders?
Jan 11Does COLTENE Holding (VTX:CLTN) Have A Healthy Balance Sheet?
Dec 17Is It Time To Consider Buying COLTENE Holding AG (VTX:CLTN)?
Dec 03COLTENE Holding's (VTX:CLTN) Shareholders Are Down 25% On Their Shares
Nov 20Shorn Like A Sheep: Analysts Just Shaved Their COLTENE Holding AG (VTX:CLTN) Forecasts Dramatically
Jun 22Revenue & Expenses BreakdownBeta
How COLTENE Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 243 | 12 | 97 | 0 |
30 Sep 23 | 253 | 18 | 98 | 0 |
30 Jun 23 | 264 | 24 | 100 | 0 |
31 Mar 23 | 265 | 25 | 101 | 0 |
31 Dec 22 | 267 | 26 | 102 | 0 |
30 Sep 22 | 269 | 26 | 103 | 0 |
30 Jun 22 | 271 | 26 | 103 | 0 |
31 Mar 22 | 275 | 29 | 103 | 0 |
31 Dec 21 | 279 | 32 | 102 | 0 |
30 Sep 21 | 284 | 29 | 100 | 0 |
30 Jun 21 | 288 | 26 | 97 | 0 |
31 Mar 21 | 268 | 17 | 94 | 0 |
31 Dec 20 | 248 | 8 | 92 | 0 |
30 Sep 20 | 245 | 10 | 98 | 0 |
30 Jun 20 | 242 | 12 | 104 | 0 |
31 Mar 20 | 258 | 16 | 108 | 0 |
31 Dec 19 | 274 | 20 | 111 | 0 |
30 Sep 19 | 264 | 19 | 106 | 0 |
30 Jun 19 | 254 | 19 | 100 | 0 |
31 Mar 19 | 229 | 18 | 91 | 0 |
31 Dec 18 | 204 | 17 | 82 | 0 |
30 Sep 18 | 190 | 18 | 77 | 0 |
30 Jun 18 | 176 | 19 | 71 | 0 |
31 Mar 18 | 172 | 19 | 70 | 0 |
31 Dec 17 | 168 | 19 | 68 | 0 |
30 Sep 17 | 166 | 18 | 67 | 0 |
30 Jun 17 | 163 | 16 | 66 | 0 |
31 Mar 17 | 162 | 17 | 66 | 0 |
31 Dec 16 | 161 | 17 | 65 | 0 |
30 Sep 16 | 159 | 17 | 64 | 0 |
30 Jun 16 | 157 | 17 | 63 | 0 |
31 Mar 16 | 156 | 15 | 63 | 0 |
31 Dec 15 | 155 | 13 | 62 | 0 |
30 Sep 15 | 157 | 14 | 64 | 0 |
30 Jun 15 | 160 | 14 | 65 | 0 |
31 Mar 15 | 161 | 15 | 65 | 0 |
31 Dec 14 | 162 | 16 | 65 | 0 |
30 Sep 14 | 162 | 15 | 60 | 0 |
30 Jun 14 | 161 | 14 | 56 | 0 |
31 Mar 14 | 161 | 13 | 57 | 0 |
31 Dec 13 | 160 | 13 | 57 | 0 |
30 Sep 13 | 160 | 12 | 57 | 0 |
30 Jun 13 | 160 | 12 | 56 | 0 |
Quality Earnings: CLTN has high quality earnings.
Growing Profit Margin: CLTN's current net profit margins (4.9%) are lower than last year (9.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CLTN's earnings have grown by 7.1% per year over the past 5 years.
Accelerating Growth: CLTN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CLTN had negative earnings growth (-54%) over the past year, making it difficult to compare to the Medical Equipment industry average (-7.1%).
Return on Equity
High ROE: CLTN's Return on Equity (12.3%) is considered low.